Abstract
Due to the difference of intracellular microenvironment between tumour and normal cells, stimuli-responsive supramolecular assemblies have been widely designed for accurate drug delivery and controlled release. This study introduces a reduction-triggered drug delivery system that encapsulates drugs in mesoporous silica nanomaterials (MSNs) pores using a supramolecular nanovalve based on host–guest interactions between pillar[5]arene and viologen groups. PEGylated pillar[5]arene (the host) can encircle viologen stalks (the guest), which have been grafted onto the MSNs surface in advance, and separate from viologen when it encounters a reducing agent. In vitro drug release experiments were conducted under various pH conditions and reducing environments to control drug release. Furthermore, cytotoxicity studies revealed that the drug-loaded nanoparticles exhibited low cytotoxicity to LO2 cells but effectively induced apoptosis in HepG2 cells. This work contributes to the development of targeted intracellular drug delivery in tumour clinical therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.